Using β-glycerophosphate-treated vascular smooth muscle cells (VSMCs) and CKD mouse models, we employed transcriptomic analysis, FNDC5 genetic knockout, and overexpression strategies to dissect HK1’s mechanistic contribution. The gene discussed is HK1; the disease is chronic kidney disease.